Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2014

01.12.2014 | Research Article

Community pharmacists’ knowledge of diabetes management during Ramadan in Egypt

verfasst von: Mohamed E. K. Amin, Betty Chewning

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background Although Muslim diabetic patients may be aware of their religious exemption from fasting, many still fast and adjust their medication regimens accordingly. Pharmacists have a significant potential to identify and prevent harm from medication misuse in Ramadan. Objectives This study examines Egyptian pharmacists’ knowledge regarding management of diabetes during Ramadan. It also explores pharmacists’ willingness to attend a 1 day workshop on medication regimen adjustment during Ramadan. Setting Community pharmacies throughout Alexandria, Egypt. Methods A cross-sectional study using a pretested self-administered survey was conducted among a random sample of community pharmacists. The survey included three knowledge questions relevant to counseling diabetic patients during Ramadan. Questions covered the recommended timing and dosing for metformin and insulin as well as the safe blood glucose range required for diabetic patients to safely continue their fast. Using logistic regression, a model was estimated to predict pharmacists’ willingness to attend a workshop on the adjustment of medication regimens during Ramadan. Content analysis was used to analyze pharmacists’ answers to the question concerning what they would like the workshop to cover. Main outcome measure Pharmacists’ aggregate scores for all three diabetes management knowledge questions and pharmacists’ willingness to attend a workshop on the adjustment of medication regimens during Ramadan. Results Ninety three percent of the 298 approached pharmacists agreed to participate. Forty three pharmacists (15.9 %) did not know the correct answer to any question, 118(43.7 %) 24 answered one correctly, 86 (31.9 %) answered two correctly and only 23 (8.5 %) answered all 25 three correctly. Confidence in therapeutic knowledge regarding medication regimen 26 adjustment during Ramadan was not associated with the pharmacists’ knowledge of diabetes management during Ramadan. One hundred seventy five (63.6 %) pharmacists wanted to attend a workshop on adjusting medication regimens during Ramadan. This was significantly associated with pharmacists being Muslim (OR 3.52, CI 1.70–7.27) and of younger age (OR 30 = 0.98, CI 0.96–0.99978). Pharmacists offered specific content and communication process 31 suggestions for the workshop content. Conclusion This study identifies variability among community pharmacists’ knowledge of diabetes management during Ramadan. It also shows willingness among the majority of pharmacists to learn more about the topic
Literatur
1.
Zurück zum Zitat Kettani H. World Muslim Population: 1950–2020. Int J Environ Sci Dev. 2010;1(2):127–70.CrossRef Kettani H. World Muslim Population: 1950–2020. Int J Environ Sci Dev. 2010;1(2):127–70.CrossRef
2.
Zurück zum Zitat Arafa N, Amin G. The epidemiology of diabetes mellitus in Egypt: Results of a National Survey. Egypt J Comm Med. 2010;28:29–43. Arafa N, Amin G. The epidemiology of diabetes mellitus in Egypt: Results of a National Survey. Egypt J Comm Med. 2010;28:29–43.
3.
Zurück zum Zitat El-Zanaty F, Way A. Egypt demographic and health survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International; 2009. El-Zanaty F, Way A. Egypt demographic and health survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International; 2009.
4.
Zurück zum Zitat Al-Mendalawi MD. Effects of Ramadan fasting on glucose levels and serum lipid profile among type 2 diabetic patients. Saudi Med J. 2011;32(6):647.PubMed Al-Mendalawi MD. Effects of Ramadan fasting on glucose levels and serum lipid profile among type 2 diabetic patients. Saudi Med J. 2011;32(6):647.PubMed
5.
Zurück zum Zitat Alberti H, Boudriga N, Nabli M. Lower attendance rates and higher fasting glucose levels in the month of Ramadan in patients with diabetes in a Muslim country. Diabet Med. 2008;25(5):637–8.PubMedCrossRef Alberti H, Boudriga N, Nabli M. Lower attendance rates and higher fasting glucose levels in the month of Ramadan in patients with diabetes in a Muslim country. Diabet Med. 2008;25(5):637–8.PubMedCrossRef
6.
Zurück zum Zitat Chan F, Slater C, Syed AA. Diabetes and Ramadan. Fasts after bariatric surgery. BMJ. 2010;341:c3706.PubMedCrossRef Chan F, Slater C, Syed AA. Diabetes and Ramadan. Fasts after bariatric surgery. BMJ. 2010;341:c3706.PubMedCrossRef
7.
Zurück zum Zitat Khaled BM, Belbraouet S. Effect of Ramadan fasting on anthropometric parameters and food consumption in 276 type 2 diabetic obese women. Int J Diabetes Dev Ctries. 2009;29(2):62–8.PubMedCentralPubMedCrossRef Khaled BM, Belbraouet S. Effect of Ramadan fasting on anthropometric parameters and food consumption in 276 type 2 diabetic obese women. Int J Diabetes Dev Ctries. 2009;29(2):62–8.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Salman H, et al. Ramadan fasting in diabetic children in Riyadh. Diabet Med. 1992;9(6):583–4.PubMedCrossRef Salman H, et al. Ramadan fasting in diabetic children in Riyadh. Diabet Med. 1992;9(6):583–4.PubMedCrossRef
10.
Zurück zum Zitat Sifri AlS, et al. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: A randomised trial. Int J Clin Pract. 2011;65(11):1132–40.PubMedCentralPubMedCrossRef Sifri AlS, et al. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: A randomised trial. Int J Clin Pract. 2011;65(11):1132–40.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Bakiner O, et al. Repaglinide plus single-dose insulin glargine: A safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Acta Diabetol. 2009;46(1):63–5.PubMedCrossRef Bakiner O, et al. Repaglinide plus single-dose insulin glargine: A safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Acta Diabetol. 2009;46(1):63–5.PubMedCrossRef
12.
Zurück zum Zitat Bin-Abbas BS. Insulin pump therapy during Ramadan fasting in type 1 diabetic adolescents. Ann Saudi Med. 2008;28(4):305–6.PubMedCrossRef Bin-Abbas BS. Insulin pump therapy during Ramadan fasting in type 1 diabetic adolescents. Ann Saudi Med. 2008;28(4):305–6.PubMedCrossRef
13.
Zurück zum Zitat Hassanein M, et al. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: Results of the VECTOR study. Curr Med Res Opin. 2011;27(7):1367–74.PubMedCrossRef Hassanein M, et al. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: Results of the VECTOR study. Curr Med Res Opin. 2011;27(7):1367–74.PubMedCrossRef
14.
Zurück zum Zitat Hui E, et al. Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. Int J Clin Pract. 2010;64(8):1095–9.PubMedCrossRef Hui E, et al. Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. Int J Clin Pract. 2010;64(8):1095–9.PubMedCrossRef
15.
Zurück zum Zitat Salti I. Diabetes, and G. Ramadan Study, Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan. Diabet Med. 2009;26(12):1255–61.PubMedCrossRef Salti I. Diabetes, and G. Ramadan Study, Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan. Diabet Med. 2009;26(12):1255–61.PubMedCrossRef
16.
Zurück zum Zitat Sari R, et al. The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res. 2004;30(2):169–77.PubMedCrossRef Sari R, et al. The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res. 2004;30(2):169–77.PubMedCrossRef
17.
Zurück zum Zitat Zargar AH, et al. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast. Int J Clin Pract. 2010;64(8):1090–4.PubMedCrossRef Zargar AH, et al. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast. Int J Clin Pract. 2010;64(8):1090–4.PubMedCrossRef
18.
Zurück zum Zitat Salti I, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306–11.PubMedCrossRef Salti I, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306–11.PubMedCrossRef
19.
Zurück zum Zitat Almaatouq MA. Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan. Diabetes Metab Syndr Obes. 2012;5:109–19.PubMedCentralPubMedCrossRef Almaatouq MA. Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan. Diabetes Metab Syndr Obes. 2012;5:109–19.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Mygind A, et al. Patient perspectives on type 2 diabetes and medicine use during Ramadan among Pakistanis in Denmark. Int J Clin Pharm. 2013;35(2):281–8.PubMedCrossRef Mygind A, et al. Patient perspectives on type 2 diabetes and medicine use during Ramadan among Pakistanis in Denmark. Int J Clin Pharm. 2013;35(2):281–8.PubMedCrossRef
21.
Zurück zum Zitat Gaborit B, et al. Ramadan fasting with diabetes: An interview study of inpatients’ and general practitioners’ attitudes in the South of France. Diabetes Metab. 2011;37(5):395–402.PubMedCrossRef Gaborit B, et al. Ramadan fasting with diabetes: An interview study of inpatients’ and general practitioners’ attitudes in the South of France. Diabetes Metab. 2011;37(5):395–402.PubMedCrossRef
22.
Zurück zum Zitat Peeters, B., et al. Ramadan fasting and diabetes: An observational study among Turkish migrants in Belgium. Prim Care Diabetes. 2012; p. 293–6. Peeters, B., et al. Ramadan fasting and diabetes: An observational study among Turkish migrants in Belgium. Prim Care Diabetes. 2012; p. 293–6.
23.
Zurück zum Zitat Taher A, Stuart EW, Hegazy I. The pharmacist’s role in the Egyptian pharmaceutical market. Int J Pharm Healthc Mark. 2012;6(2):140–55.CrossRef Taher A, Stuart EW, Hegazy I. The pharmacist’s role in the Egyptian pharmaceutical market. Int J Pharm Healthc Mark. 2012;6(2):140–55.CrossRef
24.
Zurück zum Zitat Amin, M., Pharmacists’ Role in Adjusting Medication Regimens for Muslim Patients in Ramadan, University of Wisconsin-Madison: Madison, Wisconsin; 2013. Amin, M., Pharmacists’ Role in Adjusting Medication Regimens for Muslim Patients in Ramadan, University of Wisconsin-Madison: Madison, Wisconsin; 2013.
26.
Zurück zum Zitat Begum Y. GP guide to managing patients who wish to fast during Ramadan. Prescriber. 2011;22(13–14):14–21. Begum Y. GP guide to managing patients who wish to fast during Ramadan. Prescriber. 2011;22(13–14):14–21.
27.
Zurück zum Zitat Bravis V, et al. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med. 2010;27(3):327–31.PubMedCrossRef Bravis V, et al. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med. 2010;27(3):327–31.PubMedCrossRef
28.
Zurück zum Zitat Hassanein MM. Diabetes and Ramadan: How to achieve a safer fast for Muslims with diabetes. Br J Diabetes Vasc Dis. 2010;10(5):246–50.CrossRef Hassanein MM. Diabetes and Ramadan: How to achieve a safer fast for Muslims with diabetes. Br J Diabetes Vasc Dis. 2010;10(5):246–50.CrossRef
29.
Zurück zum Zitat Hui E, et al. Management of people with diabetes wanting to fast during Ramadan. BMJ. 2010;340:c3053.PubMedCrossRef Hui E, et al. Management of people with diabetes wanting to fast during Ramadan. BMJ. 2010;340:c3053.PubMedCrossRef
31.
Zurück zum Zitat Qaisi VG. Increasing awareness of health care concerns during Ramadan. J Am Pharm Assoc (Wash). 2001;41(4):511. Qaisi VG. Increasing awareness of health care concerns during Ramadan. J Am Pharm Assoc (Wash). 2001;41(4):511.
32.
Zurück zum Zitat Holdford D. Content analysis methods for conducting research in social and administrative pharmacy. Res Social Adm Pharm. 2008;4(2):173–81.PubMedCrossRef Holdford D. Content analysis methods for conducting research in social and administrative pharmacy. Res Social Adm Pharm. 2008;4(2):173–81.PubMedCrossRef
33.
Zurück zum Zitat Wilbur, K., Al-Tawengi K, Remoden E, How do pharmacists advise diabetes patient self-management during the holy month of Ramadan?, in ISPOR 15th Annual European Conference. 2012: Berlin, Germany. Wilbur, K., Al-Tawengi K, Remoden E, How do pharmacists advise diabetes patient self-management during the holy month of Ramadan?, in ISPOR 15th Annual European Conference. 2012: Berlin, Germany.
34.
Zurück zum Zitat Mohamed Ibrahim OH. Assessment of Egyptian pharmacists’ attitude, behaviors, and preferences related to continuing education. Int J Clin Pharm. 2012;34(2):358–63.PubMedCrossRef Mohamed Ibrahim OH. Assessment of Egyptian pharmacists’ attitude, behaviors, and preferences related to continuing education. Int J Clin Pharm. 2012;34(2):358–63.PubMedCrossRef
35.
Zurück zum Zitat Amin ME, Chewning BA, Wahdan AM. Sources of drug information for patients with chronic conditions in Alexandria, Egypt. Int J Pharm Pract. 2011;19(1):13–20.PubMedCrossRef Amin ME, Chewning BA, Wahdan AM. Sources of drug information for patients with chronic conditions in Alexandria, Egypt. Int J Pharm Pract. 2011;19(1):13–20.PubMedCrossRef
Metadaten
Titel
Community pharmacists’ knowledge of diabetes management during Ramadan in Egypt
verfasst von
Mohamed E. K. Amin
Betty Chewning
Publikationsdatum
01.12.2014
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2014
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-0019-6

Weitere Artikel der Ausgabe 6/2014

International Journal of Clinical Pharmacy 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.